Baseline cognitive functions among elderly patients with localised breast cancer-Reference-Cited by-同舟云学术

Baseline cognitive functions among elderly patients with localised breast cancer

Published:2014-09 Issue:13 Volume:50 Page:2181-2189
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Lange Marie,Giffard Bénédicte,Noal Sabine,Rigal Olivier,Kurtz Jean-Emmanuel,Heutte Natacha,Lévy Christelle,Allouache Djelila,Rieux Chantal,Fel Johan Le,Daireaux Aurélie,Clarisse Bénédicte,Veyret Corinne,Barthélémy Philippe,Longato Nadine,Eustache Francis,Joly Florence

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Cognitive dysfunction and cancer: which consequences in terms of disease management?;Joly;Psychooncology,2011

2. Brain vulnerability to chemotherapy toxicities;Ahles;Psychooncology,2012

3. Opening up the window into “Chemobrain”: a neuroimaging review;Scherling;Sensors (Basel),2013

4. Candidate mechanisms for chemotherapy-induced cognitive changes;Ahles;Nat Rev Cancer,2007

5. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study;Hurria;J Am Geriatr Soc,2006

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supportive care needs, quality of life and social support among elderly colorectal cancer patients undergoing chemotherapy: a longitudinal study;Frontiers in Oncology;2024-08-21

2. Association between Cognitive Function and Physical Function, Frailty, and Quality of Life in Older Breast Cancer Survivors;Cancers;2024-07-31

3. Synapses tagged, memories kept: synaptic tagging and capture hypothesis in brain health and disease;Philosophical Transactions of the Royal Society B: Biological Sciences;2024-06-10

4. Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape;Current Oncology;2023-12-26

5. Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice;Science Translational Medicine;2023-09-27